Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Reporting“
Suchtreffer
Begriffe & Kennungen
Adempas · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAdempas · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAdempas · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAdenuric · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAdenuric · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAdjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAdrovance · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAdtralza · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAdtralza · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAdvagraf · 4.8 · 17 Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the m
Eintrag öffnenAdvate · 4.8 · Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93
Eintrag öffnenAdvate · 4.8 · Clinical studies with ADVATE included 418 subjects with at least one exposure to ADVATE reporting in total 93
Eintrag öffnenAdvate · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAdvate · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAdvate · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAdvate · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenAdvate · 4.8 · Table 2 provides the frequency of adverse reactions in clinical trials and from spontaneous reporting, accordi
Eintrag öffnenAdvate · 4.8 · Table 2 provides the frequency of adverse reactions in clinical trials and from spontaneous reporting, accordi
Eintrag öffnenAdynovi · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenAdynovi · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnen